2viw

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
[[Image:2viw.jpg|left|200px]]
[[Image:2viw.jpg|left|200px]]
-
{{Structure
+
<!--
-
|PDB= 2viw |SIZE=350|CAPTION= <scene name='initialview01'>2viw</scene>, resolution 2.05&Aring;
+
The line below this paragraph, containing "STRUCTURE_2viw", creates the "Structure Box" on the page.
-
|SITE= <scene name='pdbsite=AC1:Act+Binding+Site+For+Chain+A'>AC1</scene> and <scene name='pdbsite=AC2:D56+Binding+Site+For+Chain+A'>AC2</scene>
+
You may change the PDB parameter (which sets the PDB file loaded into the applet)
-
|LIGAND= <scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=D56:4-(2-AMINOETHOXY)-N-(3-CHLORO-2-ETHOXY-5-PIPERIDIN-1-YLPHENYL)-3,5-DIMETHYLBENZAMIDE'>D56</scene>
+
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
-
|ACTIVITY= <span class='plainlinks'>[http://en.wikipedia.org/wiki/U-plasminogen_activator U-plasminogen activator], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.73 3.4.21.73] </span>
+
or leave the SCENE parameter empty for the default display.
-
|GENE=
+
-->
-
|DOMAIN=
+
{{STRUCTURE_2viw| PDB=2viw | SCENE= }}
-
|RELATEDENTRY=[[1c5w|1C5W]], [[1c5x|1C5X]], [[1c5y|1C5Y]], [[1c5z|1C5Z]], [[1ejn|1EJN]], [[1fv9|1FV9]], [[1gi7|1GI7]], [[1gi9|1GI9]], [[1gj7|1GJ7]], [[1gj8|1GJ8]], [[1gj9|1GJ9]], [[1gjc|1GJC]], [[1kdu|1KDU]], [[1o5c|1O5C]], [[1owd|1OWD]], [[1owh|1OWH]], [[1owj|1OWJ]], [[1sc8|1SC8]], [[1f5l|1F5L]], [[1f92|1F92]], [[1gi8|1GI8]], [[1gja|1GJA]], [[1gjb|1GJB]], [[1gjd|1GJD]], [[1lmw|1LMW]], [[1o3p|1O3P]], [[1o5a|1O5A]], [[1o5b|1O5B]], [[1owe|1OWE]], [[1owi|1OWI]], [[1owk|1OWK]], [[1sqa|1SQA]], [[1sqo|1SQO]], [[1sqt|1SQT]], [[1u6q|1U6Q]], [[1vj9|1VJ9]], [[1w0z|1W0Z]], [[1w10|1W10]], [[1w12|1W12]], [[1w14|1W14]], [[1vja|1VJA]], [[1w11|1W11]], [[1w13|1W13]], [[2jde|2JDE]], [[2vin|2VIN]], [[2vio|2VIO]], [[2vip|2VIP]], [[2viq|2VIQ]], [[2viv|2VIV]]
+
-
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2viw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2viw OCA], [http://www.ebi.ac.uk/pdbsum/2viw PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=2viw RCSB]</span>
+
-
}}
+
'''FRAGMENT-BASED DISCOVERY OF MEXILETINE DERIVATIVES AS ORALLY BIOAVAILABLE INHIBITORS OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR'''
'''FRAGMENT-BASED DISCOVERY OF MEXILETINE DERIVATIVES AS ORALLY BIOAVAILABLE INHIBITORS OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR'''
Line 36: Line 33:
[[Category: Vinkovic, M.]]
[[Category: Vinkovic, M.]]
[[Category: Wallis, N G.]]
[[Category: Wallis, N G.]]
-
[[Category: blood coagulation]]
+
[[Category: Blood coagulation]]
-
[[Category: egf-like domain]]
+
[[Category: Egf-like domain]]
-
[[Category: fibrinolysis]]
+
[[Category: Fibrinolysis]]
-
[[Category: glycoprotein]]
+
[[Category: Glycoprotein]]
-
[[Category: hydrolase]]
+
[[Category: Hydrolase]]
-
[[Category: inhibitor]]
+
[[Category: Inhibitor]]
-
[[Category: kringle]]
+
[[Category: Kringle]]
-
[[Category: pharmaceutical]]
+
[[Category: Pharmaceutical]]
-
[[Category: phosphorylation]]
+
[[Category: Phosphorylation]]
-
[[Category: plasminogen activation]]
+
[[Category: Plasminogen activation]]
-
[[Category: polymorphism]]
+
[[Category: Polymorphism]]
-
[[Category: protease]]
+
[[Category: Protease]]
-
[[Category: secreted]]
+
[[Category: Secreted]]
-
[[Category: serine protease]]
+
[[Category: Serine protease]]
-
[[Category: urokinase-type plasminogen activator]]
+
[[Category: Urokinase-type plasminogen activator]]
-
[[Category: zymogen]]
+
[[Category: Zymogen]]
-
 
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 18:54:09 2008''
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 05:12:57 2008''
+

Revision as of 15:54, 4 May 2008

Image:2viw.jpg

Template:STRUCTURE 2viw

FRAGMENT-BASED DISCOVERY OF MEXILETINE DERIVATIVES AS ORALLY BIOAVAILABLE INHIBITORS OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR


Overview

Fragment-based lead discovery has been applied to urokinase-type plasminogen activator (uPA). The (R)-enantiomer of the orally active drug mexiletine 5 (a fragment hit from X-ray crystallographic screening) was the chemical starting point. Structure-aided design led to elaborated inhibitors that retained the key interactions of (R)-5 while gaining extra potency by simultaneously occupying neighboring regions of the active site. Subsequent optimization led to 15, a potent, selective, and orally bioavailable inhibitor of uPA.

About this Structure

2VIW is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activator., Frederickson M, Callaghan O, Chessari G, Congreve M, Cowan SR, Matthews JE, McMenamin R, Smith DM, Vinkovic M, Wallis NG, J Med Chem. 2008 Jan 24;51(2):183-6. Epub 2007 Dec 29. PMID:18163548 Page seeded by OCA on Sun May 4 18:54:09 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2viw"
Personal tools